Belpointe Asset Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $913K | Buy |
9,562
+1,384
| +17% | +$133K | 0.03% | 517 |
|
|
2026
Q1 | $847K | Sell |
8,178
-3,094
| -27% | -$351K | 0.03% | 516 |
|
|
2025
Q4 | $1.14M | Buy |
11,272
+8,228
| +270% | +$893K | 0.04% | 377 |
|
|
2025
Q3 | $375K | Sell |
3,044
-472
| -13% | -$58.6K | 0.01% | 722 |
|
|
2025
Q2 | $422K | Buy |
3,516
+335
| +11% | +$44.7K | 0.02% | 635 |
|
|
2025
Q1 | $469K | Buy |
3,181
+206
| +7% | +$31.5K | 0.02% | 585 |
|
|
2024
Q4 | $471K | Sell |
2,975
-1
| -0% | -$164 | 0.03% | 525 |
|
|
2024
Q3 | $485K | Buy |
2,976
+213
| +8% | +$31.6K | 0.03% | 512 |
|
|
2024
Q2 | $377K | Sell |
2,763
-162
| -6% | -$22.5K | 0.03% | 518 |
|
|
2024
Q1 | $448K | Sell |
2,925
-3
| -0.1% | -$448 | 0.03% | 459 |
|
|
2023
Q4 | $418K | Sell |
2,928
-160
| -5% | -$21.3K | 0.04% | 420 |
|
|
2023
Q3 | $405K | Buy |
3,088
+300
| +11% | +$45.6K | 0.04% | 392 |
|
|
2023
Q2 | $443K | Sell |
2,788
-2,257
| -45% | -$364K | 0.05% | 339 |
|
|
2023
Q1 | $798K | Buy |
5,045
+483
| +11% | +$72.4K | 0.04% | 398 |
|
|
2022
Q4 | $640K | Buy |
4,562
+1,083
| +31% | +$154K | 0.04% | 439 |
|
|
2022
Q3 | $447K | Buy |
3,479
+906
| +35% | +$131K | 0.03% | 544 |
|
|
2022
Q2 | $363K | Buy |
2,573
+26
| +1% | +$3.71K | 0.02% | 613 |
|
|
2022
Q1 | $355K | Sell |
2,547
-122
| -5% | -$18.7K | 0.02% | 658 |
|
|
2021
Q4 | $465K | Sell |
2,669
-254
| -9% | -$42.3K | 0.03% | 540 |
|
|
2021
Q3 | $484K | Buy |
2,923
+789
| +37% | +$136K | 0.03% | 521 |
|
|
2021
Q2 | $384K | Buy |
2,134
+101
| +5% | +$18.4K | 0.03% | 581 |
|
|
2021
Q1 | $392K | Sell |
2,033
-131
| -6% | -$25.2K | 0.03% | 508 |
|
|
2020
Q4 | $437K | Buy |
2,164
+446
| +26% | +$92.3K | 0.04% | 441 |
|
|
2020
Q3 | $361K | Buy |
1,718
+116
| +7% | +$25.8K | 0.04% | 387 |
|
|
2020
Q2 | $352K | Buy |
1,602
+382
| +31% | +$76.3K | 0.05% | 373 |
|
|
2020
Q1 | $211K | Sell |
1,220
-7
| -0.6% | -$1.16K | 0.04% | 415 |
|
|
2019
Q4 | $189K | Buy |
1,227
+492
| +67% | +$73.5K | 0.02% | 556 |
|
|
2019
Q3 | $112K | Sell |
735
-30
| -4% | -$4.74K | 0.02% | 636 |
|
|
2019
Q2 | $117K | Sell |
765
-479
| -39% | -$73.2K | 0.02% | 550 |
|
|
2019
Q1 | $200K | Buy |
1,244
+472
| +61% | +$73.2K | 0.04% | 307 |
|
|
2018
Q4 | $119K | Sell |
772
-438
| -36% | -$68.2K | 0.03% | 447 |
|
|
2018
Q3 | $182K | Buy |
+1,210
| New | +$172K | 0.03% | 477 |
|
|
2017
Q4 | – | Sell |
-2,396
| Closed | -$316K | – | 466 |
|
|
2017
Q3 | $316K | Buy |
+2,396
| New | +$322K | 0.07% | 303 |
|
Other funds holding CLX
CIM
VF
MPMG
BHIA
KCM
SIS
Belpointe Asset Management's CLX Position: Q2 2026 in Review
Belpointe Asset Management increased its Clorox (CLX) stake by 17% in Q2 2026, buying an estimated $133K and bringing the position to 9,562 shares worth $913K. The position accounts for 0.03% of the portfolio, ranked #517.
Belpointe Asset Management first reported a position in CLX in Q3 2017 and has held it in 33 quarters since. The position peaked at $1.14M in Q4 2025. 434 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Belpointe Asset Management held 9,562 shares of Clorox worth $913K as of Q2 2026.
- Belpointe Asset Management bought 1,384 Clorox shares in Q2 2026, an estimated $133K.
- Clorox made up 0.03% of Belpointe Asset Management's portfolio in Q2 2026, its #517 holding.
- Belpointe Asset Management first reported a position in Clorox in Q3 2017 and has held it in 33 quarters since.
- Belpointe Asset Management's Clorox position peaked at $1.14M in Q4 2025.
- 434 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.